{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:04:11Z","timestamp":1790370251470,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ymgme.2026.110202","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:19:14Z","timestamp":1783178354000},"page":"110202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Biomarkers and surrogate endpoints for drug development in propionic acidemia"],"prefix":"10.1016","volume":"149","author":[{"given":"Agnieszka","family":"Jurecka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Scholl-B\u00fcrgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Zori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Vockley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Dionisi-Vici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2026.110202_bb0005","series-title":"The Metabolic & Molecular Bases of Inherited Disease","article-title":"Disorders of propionate and methylmalonate metabolism","author":"Fenton","year":"2006"},{"key":"10.1016\/j.ymgme.2026.110202_bb0010","first-page":"121","article-title":"Practical management of organic acidemias","author":"Chapman","year":"2019","journal-title":"Transl. Sci. Rare Dis."},{"key":"10.1016\/j.ymgme.2026.110202_bb0015","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/MOP.0000000000000422","article-title":"Methylmalonic and propionic acidemias: clinical management update","volume":"28","author":"Fraser","year":"2016","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.ymgme.2026.110202_bb0020","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/jimd.12613","article-title":"Safety, efficacy, and timing of transplantation(s) in propionic and methylmalonic aciduria","volume":"46","author":"Chakrapani","year":"2023","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110202_bb0025","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/jimd.12648","article-title":"The impact of liver transplantation on health-related quality of life in (acute) intoxication-type inborn errors of metabolism","volume":"46","author":"Greco","year":"2023","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110202_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.70100","article-title":"The evolving trend of liver transplantation in metabolic diseases: from origins to current perspectives","volume":"48","author":"Pietrobattista","year":"2025","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110202_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107612","article-title":"Challenges and strategies for clinical trials in propionic and methylmalonic acidemias","volume":"139","author":"Vockley","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110202_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1098454","article-title":"Study design challenges and strategies in clinical trials for rare diseases: lessons learned from pantothenate kinase-associated neurodegeneration","volume":"14","author":"Videnovic","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ymgme.2026.110202_bb0045","unstructured":"21CFR314.126."},{"key":"10.1016\/j.ymgme.2026.110202_bb0050","series-title":"US Department of Health and Human Services, Center for Drug Evaluation and Research (CDER)","article-title":"Expedited Programs for Serious Conditions \u2013 Drugs and Biologics, guidance for industry","year":"2014"},{"key":"10.1016\/j.ymgme.2026.110202_bb0055","series-title":"Guideline on Clinical Trials in Small Populations","year":"2006"},{"key":"10.1016\/j.ymgme.2026.110202_bb0060","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13023-014-0130-8","article-title":"Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia","volume":"9","author":"Baumgartner","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2026.110202_bb0065","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.pcl.2017.11.003","article-title":"Inborn errors of metabolism with acidosis: organic Acidemias and defects of pyruvate and ketone body metabolism","volume":"65","author":"Schillaci","year":"2018","journal-title":"Pediatr. Clin. North Am."},{"key":"10.1016\/j.ymgme.2026.110202_bb0070","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/neuonc\/nox242","article-title":"The FDA NIH biomarkers, EndpointS, and other tools (BEST) resource in neuro-oncology","volume":"20","author":"Cagney","year":"2018","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ymgme.2026.110202_bb0075","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ymgme.2022.07.015","article-title":"The transformation of drug development for the 21st century: time for a change","volume":"137","author":"Kakkis","year":"2022","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110202_bb0080","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/jimd.12636","article-title":"Biomarkers to predict disease progression and therapeutic response in isolated methylmalonic acidemia","volume":"46","author":"Manoli","year":"2023","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110202_bb0085","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/jimd.12478","article-title":"Biomarkers for drug development in propionic and methylmalonic acidemias","volume":"45","author":"Longo","year":"2022","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110202_bb0090","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/jimd.12586","article-title":"How guideline development has informed clinical research for organic acidurias (et vice versa)","volume":"46","author":"Forny","year":"2023","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110202_bb0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/jimd.12665","article-title":"Gene therapy for organic acidemias: lessons learned from methylmalonic and propionic acidemia","volume":"47","author":"Chandler","year":"2024","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110202_bb0100","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1055\/s-0029-1231065","article-title":"Stroke-like episodes in propionic acidemia caused by central focal metabolic decompensation","volume":"40","author":"Scholl-Burgi","year":"2009","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ymgme.2026.110202_bb0105","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10545-008-0796-y","article-title":"The relation of cerebrospinal fluid and plasma glycine levels in propionic acidaemia, a 'ketotic hyperglycinaemia'","volume":"31","author":"Scholl-Burgi","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110202_bb0110","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ymgme.2005.11.016","article-title":"Metabolic changes associated with hyperammonemia in patients with propionic acidemia","volume":"88","author":"Filipowicz","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110202_bb0115","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/jimd.12287","article-title":"Plasma methylcitric acid and its correlations with other disease biomarkers: the impact in the follow up of patients with propionic and methylmalonic acidemia","volume":"43","author":"Maines","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110202_bb0120","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/jnc.13544","article-title":"2-Methylcitric acid impairs glutamate metabolism and induces permeability transition in brain mitochondria","volume":"137","author":"Amaral","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2026.110202_bb0125","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/ajt.13027","article-title":"Early and late complications after liver transplantation for propionic acidemia in children: a two centers study","volume":"15","author":"Charbit-Henrion","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.ymgme.2026.110202_bb0130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ymgme.2012.10.022","article-title":"Improved neurologic prognosis for a patient with propionic acidemia who received early living donor liver transplantation","volume":"108","author":"Nagao","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110202_bb0135","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ymgme.2017.07.003","article-title":"Anaplerotic therapy in propionic acidemia","volume":"122","author":"Longo","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110202_bb0140","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13023-020-1347-3","article-title":"Understanding acute metabolic decompensation in propionic and methylmalonic acidemias: a deep metabolic phenotyping approach","volume":"15","author":"Haijes","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2026.110202_bb0145","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/s41436-021-01173-2","article-title":"Severity modeling of propionic acidemia using clinical and laboratory biomarkers","volume":"23","author":"Shchelochkov","year":"2021","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2026.110202_bb0150","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1750-1172-8-4","article-title":"Brain damage in methylmalonic aciduria: 2-methylcitrate induces cerebral ammonium accumulation and apoptosis in 3D organotypic brain cell cultures","volume":"8","author":"Jafari","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2026.110202_bb0155","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ymgme.2016.07.013","article-title":"Ammonium accumulation is a primary effect of 2-methylcitrate exposure in an in vitro model for brain damage in methylmalonic aciduria","volume":"119","author":"Cudre-Cung","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110202_bb0160","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48885-9","article-title":"Assessment of methylcitrate and methylcitrate to citrate ratio in dried blood spots as biomarkers for inborn errors of propionate metabolism","volume":"9","author":"Al-Dirbashi","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymgme.2026.110202_bb0165","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrendo.2015.129","article-title":"Acylcarnitines--old actors auditioning for new roles in metabolic physiology","volume":"11","author":"McCoin","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ymgme.2026.110202_bb0170","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ymgme.2013.04.008","article-title":"Differences between acylcarnitine profiles in plasma and bloodspots","volume":"110","author":"de Sain-van der Velden","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110202_bb0175","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/0969141316645824","article-title":"Quantification of 2-methylcitric acid in dried blood spots improves newborn screening for propionic and methylmalonic acidemias","volume":"24","author":"Al-Dirbashi","year":"2017","journal-title":"J. Med. Screen."},{"key":"10.1016\/j.ymgme.2026.110202_bb0180","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1373\/clinchem.2007.087775","article-title":"Rapid 2nd-tier test for measurement of 3-OH-propionic and methylmalonic acids on dried blood spots: reducing the false-positive rate for propionylcarnitine during expanded newborn screening by liquid chromatography-tandem mass spectrometry","volume":"53","author":"la Marca","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2026.110202_bb0185","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S1726-4901(10)70067-8","article-title":"Newborn screening for methylmalonic aciduria by tandem mass spectrometry: 7 years' experience from two centers in Taiwan","volume":"73","author":"Cheng","year":"2010","journal-title":"J. Chin. Med. Assoc."},{"key":"10.1016\/j.ymgme.2026.110202_bb0190","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/s41380-023-02385-5","article-title":"Intellectual disability and autism in propionic acidemia: a biomarker-behavioral investigation implicating dysregulated mitochondrial biology","volume":"29","author":"Shchelochkov","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ymgme.2026.110202_bb0195","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1399-3046.2011.01607.x","article-title":"Living-donor liver transplantation for propionic acidemia","volume":"16","author":"Kasahara","year":"2012","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.ymgme.2026.110202_bb0200","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/lt.25679","article-title":"Liver transplantation in children with propionic Acidemia: medium-term outcomes","volume":"26","author":"Curnock","year":"2020","journal-title":"Liver Transpl."},{"key":"10.1016\/j.ymgme.2026.110202_bb0205","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/petr.12804","article-title":"Improvement in the prognosis and development of patients with methylmalonic acidemia after living donor liver transplant","volume":"20","author":"Sakamoto","year":"2016","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.ymgme.2026.110202_bb0210","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1097\/MPG.0000000000000626","article-title":"Liver transplantation for propionic Acidemia","volume":"64","author":"Silva","year":"2017","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.ymgme.2026.110202_bb0215","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/lt.25344","article-title":"The role of liver transplantation in propionic Acidemia","volume":"24","author":"Quintero","year":"2018","journal-title":"Liver Transpl."},{"key":"10.1016\/j.ymgme.2026.110202_bb0220","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s13023-018-0963-7","article-title":"Hyperammonaemia in classic organic acidaemias: a review of the literature and two case histories","volume":"13","author":"Haberle","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2026.110202_bb0225","series-title":"Table of surrogate endpoints that were the basis of drug approval or licensure","year":"2025"},{"key":"10.1016\/j.ymgme.2026.110202_bb0230","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S1474-4422(11)70155-7","article-title":"FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study","volume":"10","author":"Suomalainen","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ymgme.2026.110202_bb0235","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.174097","article-title":"Lipodystrophy in methylmalonic acidemia associated with elevated FGF21 and abnormal methylmalonylation","volume":"9","author":"Manoli","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymgme.2026.110202_bb0240","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mito.2014.10.006","article-title":"GDF15 is a novel biomarker to evaluate efficacy of pyruvate therapy for mitochondrial diseases","volume":"20","author":"Fujita","year":"2015","journal-title":"Mitochondrion"},{"key":"10.1016\/j.ymgme.2026.110202_bb0245","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s10545-018-0244-6","article-title":"Fibroblast growth factor 21 as a biomarker for long-term complications in organic acidemias","volume":"41","author":"Molema","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110202_bb0250","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124351","article-title":"FGF21 underlies a hormetic response to metabolic stress in methylmalonic acidemia","volume":"3","author":"Manoli","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymgme.2026.110202_bb0255","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10545-017-0124-5","article-title":"Flux analysis of inborn errors of metabolism","volume":"41","author":"Reijngoud","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110202_bb0260","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1203\/00006450-199107000-00004","article-title":"Metabolism of 1-13C-propionate in vivo in patients with disorders of propionate metabolism","volume":"30","author":"Barshop","year":"1991","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2026.110202_bb0265","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF00295291","article-title":"Rapid prenatal and postnatal detection of inborn errors of propionate, methylmalonate, and cobalamin metabolism: a sensitive assay using cultured cells","volume":"34","author":"Willard","year":"1976","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2026.110202_bb0270","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1038\/s41436-021-01143-8","article-title":"1-(13)C-propionate breath testing as a surrogate endpoint to assess efficacy of liver-directed therapies in methylmalonic acidemia (MMA)","volume":"23","author":"Manoli","year":"2021","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2026.110202_bb0275","series-title":"Mass Spectrometry and Stable Isotopes in Nutritional and Pediatric Research","article-title":"Inborn Errors of Metabolism","author":"Huidekoper","year":"2017"},{"key":"10.1016\/j.ymgme.2026.110202_bb0280","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10545-010-9245-9","article-title":"Amino acid metabolism in patients with propionic acidaemia","volume":"35","author":"Scholl-Burgi","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110202_bb0285","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1542\/peds.27.4.522","article-title":"Idiopathic hyperglycinemia and hyperglycinuria: a new disorder of amino acid metabolism","author":"Childs","year":"1961","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2026.110202_bb0290","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1203\/00006450-197908000-00004","article-title":"Inhibition of the glycine cleavage system by branched-chain amino acid metabolites","volume":"13","author":"Kolvraa","year":"1979","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2026.110202_bb0295","first-page":"225","article-title":"Effects of the metabolites of the branched-chain amino acids and cysteamine on the glycine cleavage system","volume":"6","author":"Hayasaka","year":"1983","journal-title":"Biochem. Int."},{"key":"10.1016\/j.ymgme.2026.110202_bb0300","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1023\/A:1024048118294","article-title":"The relationship of plasma glutamine to ammonium and of glycine to acid-base balance in propionic acidaemia","volume":"26","author":"Al-Hassnan","year":"2003","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110202_bb0305","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/lt.25304","article-title":"Liver transplantation for propionic Acidemia and Methylmalonic Acidemia: perioperative management and clinical outcomes","volume":"24","author":"Critelli","year":"2018","journal-title":"Liver Transpl."},{"key":"10.1016\/j.ymgme.2026.110202_bb0310","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ymgme.2019.11.001","article-title":"Liver transplantation in propionic and methylmalonic acidemia: a single center study with literature review","volume":"128","author":"Pillai","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110202_bb0315","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s00726-009-0356-2","article-title":"Changes in plasma amino acid concentrations with increasing age in patients with propionic acidemia","volume":"38","author":"Scholl-Burgi","year":"2010","journal-title":"Amino Acids"},{"key":"10.1016\/j.ymgme.2026.110202_bb0320","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1006\/mgme.1998.2783","article-title":"Blood levels of ammonia and nitrogen scavenging amino acids in patients with inherited hyperammonemia","volume":"66","author":"Tuchman","year":"1999","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110202_bb0325","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1023\/A:1005659132147","article-title":"The glutamine paradox in a neonate with propionic acidaemia and severe hyperammonaemia","volume":"23","author":"Ierardi-Curto","year":"2000","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110202_bb0330","doi-asserted-by":"crossref","DOI":"10.3390\/metabo14080428","article-title":"Propionic acidemia, methylmalonic acidemia, and cobalamin C deficiency: comparison of untargeted metabolomic profiles","volume":"14","author":"Sidorina","year":"2024","journal-title":"Metabolites"},{"key":"10.1016\/j.ymgme.2026.110202_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.109005","article-title":"Breath biopsy in inborn errors of metabolism: a proof-of-principle study in propionic acidemia","volume":"144","author":"Shchelochkov","year":"2025","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110202_bb0340","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11011-024-01475-9","article-title":"Neurodegenerative biomarkers and inflammation in patients with propionic and methylmalonic acidemias: effect of L-carnitine treatment","volume":"40","author":"Dos Reis","year":"2024","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ymgme.2026.110202_bb0345","series-title":"Biomarker Qualification Program","year":"2025"},{"key":"10.1016\/j.ymgme.2026.110202_bb0350","series-title":"Resources for Biomarker Requestors","year":"2025"},{"key":"10.1016\/j.ymgme.2026.110202_bb0355","series-title":"European medicines agency guidance for applicants seeking scientific advice and protocol assistance","year":"2025"},{"key":"10.1016\/j.ymgme.2026.110202_bb0360","series-title":"Innovation Task Force Briefing Meetings","year":"2025"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226004853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226004853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:37:37Z","timestamp":1790368657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719226004853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":72,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1096719226004853"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110202","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers and surrogate endpoints for drug development in propionic acidemia","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110202","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110202"}}